Pharma Intelligence News Today

Some companies, however, reported a market capitalisation decline, including Gilead Sciences and Roche.

The AI and computing revolution is ushering in a new era of drug development that is poised to be better, faster and cheaper.

As per the report by Fortune Business Insights, the global biopharmaceutical CMO market size is projected to reach USD 26.49 billion in 2028, at a CAGR of...

Dublin, Nov. 17, 2023 (GLOBE NEWSWIRE) -- The

Some industries may be struggling to convince the market of their relevance after the pandemic, but Informa is making its case successfully. The events jugg

Latest news on CAR-T (Chimeric Antigen Receptor T-cell) therapy, a type of cancer treatment that involves modifying patients T-cells to recognize and attack cancer

Paris, September11, 2023 - I am pleased to announce that DrBonnie Bain, PhD has been appointed Global Head of Healthcare and will join us on 11th ...

40% of Global AI Companies Focus on Early Drug Development while AI-Powered Startups Reshape the Future of Drug DiscoveryNew industry report from Deep Pharma Intelligence has redefined the Global State of AI in Drug DiscoveryAugust 16, 2023 - London, UK: The largest profiling of the global AI in the Drug Discovery i...

Global State of AI in Drug Discovery DefinedNew Industry Report & IT-Platform Present Most Comprehensive Overview of AI in Pharma10 August 2023www.deep-pharma.tech/ai-platform  August 10, 2023 - London, UK: The largest profiling of the global AI in the Drug Discovery industry made to date has been released...

A $5.9 billion acquisition of biotech Iveric Bio by Astellas is set to accelerate development of treatments for blinding retinal diseases.